Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Diamos AG"'
Autor:
Morales Fénero C; Department of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, USA., Sacksteder RE; Department of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, USA., Diamos AG; Department of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, USA., Kimmey JM; Department of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, USA. jkimmey@ucsc.edu.
Publikováno v:
Scientific reports [Sci Rep] 2024 Nov 13; Vol. 14 (1), pp. 27805. Date of Electronic Publication: 2024 Nov 13.
Autor:
Diamos AG; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Pardhe MD; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Bergeman MH; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Kamzina AS; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., DiPalma MP; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Aman S; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Chaves A; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Lowe K; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Kilbourne J; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Hogue IB; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Mason HS; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 May 02; Vol. 14, pp. 1085911. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).
Autor:
Kamzina AS; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University; School of Life Sciences, Arizona State University; Molecular Biosciences/Biotechnology Undergraduate Program, Arizona State University., DiPalma MP; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University; School of Life Sciences, Arizona State University; Molecular Biosciences/Biotechnology Undergraduate Program, Arizona State University., Hunter JGL; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University; School of Life Sciences, Arizona State University; Molecular Biosciences/Biotechnology Undergraduate Program, Arizona State University., Diamos AG; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University; School of Life Sciences, Arizona State University; Department of Microbiology and Immunology, University of Michigan Medical School., Armer B; School of Life Sciences, Arizona State University; Molecular Biosciences/Biotechnology Undergraduate Program, Arizona State University., Mor TS; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University; School of Life Sciences, Arizona State University; Molecular Biosciences/Biotechnology Undergraduate Program, Arizona State University; tsafrir.mor@asu.edu., Mason HS; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University; School of Life Sciences, Arizona State University; Molecular Biosciences/Biotechnology Undergraduate Program, Arizona State University; hugh.mason@asu.edu.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2021 Jan 16 (167). Date of Electronic Publication: 2021 Jan 16.
Autor:
Diamos AG; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Pardhe MD; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Sun H; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Hunter JGL; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Kilbourne J; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Chen Q; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Mason HS; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Dec 04; Vol. 11, pp. 576012. Date of Electronic Publication: 2020 Dec 04 (Print Publication: 2020).
Autor:
Diamos AG; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Pardhe MD; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Sun H; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Hunter JGL; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Mor T; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Meador L; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Kilbourne J; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Chen Q; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Mason HS; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States. Electronic address: hugh.mason@asu.edu.
Publikováno v:
Vaccine [Vaccine] 2020 Apr 16; Vol. 38 (18), pp. 3455-3463. Date of Electronic Publication: 2020 Mar 12.
Autor:
Diamos AG; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Hunter JGL; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Pardhe MD; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Rosenthal SH; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Sun H; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Foster BC; School of Life Sciences, Arizona State University, Tempe, AZ, United States., DiPalma MP; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Chen Q; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Mason HS; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States.
Publikováno v:
Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2020 Jan 17; Vol. 7, pp. 472. Date of Electronic Publication: 2020 Jan 17 (Print Publication: 2019).
Autor:
Diamos AG; 1 Center for Immunology, Virology, and Vaccinology, Biodesign Institute at ASU, and School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA., Crawford JM; 1 Center for Immunology, Virology, and Vaccinology, Biodesign Institute at ASU, and School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA., Mason HS; 1 Center for Immunology, Virology, and Vaccinology, Biodesign Institute at ASU, and School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
Publikováno v:
The Journal of general virology [J Gen Virol] 2019 Jun; Vol. 100 (6), pp. 1038-1051. Date of Electronic Publication: 2019 May 20.
Autor:
Hunter JGL; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, USA.; School of Life Sciences, Arizona State University, Tempe, AZ, USA., Wilde S; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, USA., Tafoya AM; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, USA., Horsman J; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, USA., Yousif M; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, USA., Diamos AG; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, USA.; School of Life Sciences, Arizona State University, Tempe, AZ, USA., Roland KL; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, USA., Mason HS; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, USA.; School of Life Sciences, Arizona State University, Tempe, AZ, USA.
Publikováno v:
PeerJ [PeerJ] 2019 Mar 28; Vol. 7, pp. e6600. Date of Electronic Publication: 2019 Mar 28 (Print Publication: 2019).
Autor:
Diamos AG; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, School of Life Sciences, Arizona State University, Tempe, AZ, United States., Mason HS; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, School of Life Sciences, Arizona State University, Tempe, AZ, United States.
Publikováno v:
Frontiers in plant science [Front Plant Sci] 2019 Jan 09; Vol. 9, pp. 1974. Date of Electronic Publication: 2019 Jan 09 (Print Publication: 2018).
Autor:
Diamos AG; Center for Immunotherapy, Vaccines, & Virotherapy, Biodesign Institute at ASU; and School of Life Sciences, Arizona State University, Tempe, AZ 85287, United States., Larios D; Center for Immunotherapy, Vaccines, & Virotherapy, Biodesign Institute at ASU; and School of Life Sciences, Arizona State University, Tempe, AZ 85287, United States., Brown L; Center for Immunotherapy, Vaccines, & Virotherapy, Biodesign Institute at ASU; and School of Life Sciences, Arizona State University, Tempe, AZ 85287, United States., Kilbourne J; Center for Immunotherapy, Vaccines, & Virotherapy, Biodesign Institute at ASU; and School of Life Sciences, Arizona State University, Tempe, AZ 85287, United States., Kim HS; Plant Systems Engineering Research Center, KRIBB, Gwahang-ro 125, Yuseong-gu, Daejeon 34141, Republic of Korea., Saxena D; Center for Predictive Medicine for Emerging Infectious Diseases and Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, KY, United States, Center for Predictive Medicine, Louisville, KY 40202, United States., Palmer KE; Center for Predictive Medicine for Emerging Infectious Diseases and Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, KY, United States, Center for Predictive Medicine, Louisville, KY 40202, United States., Mason HS; Center for Immunotherapy, Vaccines, & Virotherapy, Biodesign Institute at ASU; and School of Life Sciences, Arizona State University, Tempe, AZ 85287, United States. Electronic address: Hugh.Mason@asu.edu.
Publikováno v:
Vaccine [Vaccine] 2019 Jan 03; Vol. 37 (1), pp. 137-144. Date of Electronic Publication: 2018 Nov 17.